Costly Edge News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Costly Edge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Costly Edge Today - Breaking & Trending Today

Fidaxomicin Favored Over Vancomycin in Real-World C diff Study

Published: May 24, 2022

Researchers compared the agents for treating both initial and recurrent Clostridioides difficile infections in a Medicare population.

Source: medscape.com

Related Topics:

Rhode IslandUnited StatesSan DiegoColleen KellyEric DubberkeErik DubberkeFidaxomicin FificidAmerican College Of GastroenterologyBrown University In ProvidenceUniversity Of WashingtonInfectious Diseases Society Of AmericaInfectious Diseases SocietyDigestive Disease WeekHigh Risk PopulationMedicare PartsCostly EdgeBrown UniversityAmerican CollegeDisease WeekHealthcare And Medical TechnologyEalth And Medical TechEalth And Med TechEalth And Medical TechnologyClinical GuidelinesClinical Research